OCULUS INC.
OVTZDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Topical Dermacyn | Phase 2 | Foot Ulcer, Diabetic | - | - |
Frequently asked questions
What is in OCULUS INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in OCULUS INC.'s (OVTZ) pipeline across Phase 2. Its lead program is Topical Dermacyn (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is OCULUS INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for OCULUS INC. (OVTZ) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track OVTZ biotech catalysts?→
Add OVTZ to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow OCULUS INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.